Short-Term Effects of COVID-19-Related Deferral of Intravitreal Injection Visits
Noy Ashkenazy, Lediana Goduni, William E Smiddy Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USACorrespondence: William E Smiddy Tel +1 305-326-6172Email wsmiddy@med.miami.eduPurpose: To determine secondary effects of the mandate...
Guardado en:
Autores principales: | Ashkenazy N, Goduni L, Smiddy WE |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e27e406ccd8a4d2a8feccc716f5116a3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Baseline Subfoveal Choroidal Thickness as a Predictor for Response to Short-Term Intravitreal Bevacizumab Injections in Diabetic Macular Edema
por: Dweikat A, et al.
Publicado: (2021) -
Treatment patterns in diabetic macular edema in Taiwan: a retrospective chart review
por: Sheu SJ, et al.
Publicado: (2018) -
Mesenchymal stem cell-derived exosomes inhibit the VEGF-A expression in human retinal vascular endothelial cells induced by high glucose
por: Guang-Hui He, et al.
Publicado: (2021) -
Effect of intravitreal aflibercept on corneal endothelial cells: a 6-month follow-up study
por: Muto T, et al.
Publicado: (2019) -
Evaluation of the Safety of Bilateral Same-Day Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Agents: Experience of a Large Korean Retina Center
por: Jang K, et al.
Publicado: (2020)